Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of aprepitant effect on aldosterone secretion in diabetic patients with low-renin hypertension
2015-001501-14Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aprepitant in type 2 diabetes mellitus (T2DM), hypertension (HTN) and Secondary hypertension (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Plasma aldosterone concentration. Started Jan 2016; status: completed.
02
Drugs
aprepitant
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)Secondary hypertension
Beyond the preview
Go deeper on 2015-001501-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001501-14.